Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/95483
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oliveira, Gabriela L. | - |
dc.contributor.author | Coelho, Ana R. | - |
dc.contributor.author | Marques, Ricardo | - |
dc.contributor.author | Oliveira, Paulo J. | - |
dc.date.accessioned | 2021-07-29T09:33:14Z | - |
dc.date.available | 2021-07-29T09:33:14Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 09254439 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/95483 | - |
dc.description.abstract | To adapt to tumoral environment conditions or even to escape chemotherapy, cells rapidly reprogram their metabolism to handle adversities and survive. Given the rapid rise of studies uncovering novel insights and therapeutic opportunities based on the role of mitochondria in tumor metabolic programing and therapeutics, this review summarizes most significant developments in the field. Taking in mind the key role of mitochondria on carcinogenesis and tumor progression due to their involvement on tumor plasticity, metabolic remodeling, and signaling re-wiring, those organelles are also potential therapeutic targets. Among other topics, we address the recent data intersecting mitochondria as of prognostic value and staging in cancer, by mitochondrial DNA (mtDNA) determination, and current inhibitors developments targeting mtDNA, OXPHOS machinery and metabolic pathways. We contribute for a holistic view of the role of mitochondria metabolism and directed therapeutics to understand tumor metabolism, to circumvent therapy resistance, and to control tumor development. | pt |
dc.description.sponsorship | Gabriela L. Oliveira is supported by project “Summer Course in Interdisciplinary Research, Development and Innovation in Cellular and Molecular Metabolism” (15-20/7/245), funded by FCT and Directorate General for Higher Education (DGES). | pt |
dc.language.iso | eng | pt |
dc.relation | POCI-01-0145-FEDER-016390 [CANCEL STEM] | pt |
dc.relation | info:eu-repo/grantAgreement/FCT/04539/2020 | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt |
dc.subject | Cancer | pt |
dc.subject | Metabolic pathways | pt |
dc.subject | Metabolism | pt |
dc.subject | Mitochondria | pt |
dc.subject | mtDNA | pt |
dc.subject.mesh | Antineoplastic Agents | pt |
dc.subject.mesh | DNA, Mitochondrial | pt |
dc.subject.mesh | Drug Resistance, Neoplasm | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Mitochondria | pt |
dc.subject.mesh | Neoplasm Staging | pt |
dc.subject.mesh | Neoplasms | pt |
dc.subject.mesh | Oxidative Phosphorylation | pt |
dc.subject.mesh | Prognosis | pt |
dc.subject.mesh | Signal Transduction | pt |
dc.subject.mesh | Tumor Microenvironment | pt |
dc.subject.mesh | Warburg Effect, Oncologic | pt |
dc.title | Cancer cell metabolism: Rewiring the mitochondrial hub | pt |
dc.type | article | - |
degois.publication.firstPage | 166016 | pt |
degois.publication.issue | 2 | pt |
degois.publication.title | BBA - Molecular Basis of Disease | pt |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S0925443920303641 | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1016/j.bbadis.2020.166016 | pt |
degois.publication.volume | 1867 | pt |
dc.date.embargo | 2021-01-01 | * |
uc.date.periodoEmbargo | 0 | pt |
item.fulltext | Com Texto completo | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairetype | article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.orcid | 0000-0002-5201-9948 | - |
Appears in Collections: | I&D CNC - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0925443920303641-main.pdf | 3.52 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License